These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 29137811)

  • 21. Toxic effects of systemic cisplatin on rat eyes and the protective effect of hesperidin against this toxicity.
    Polat N; Ciftci O; Cetin A; Yılmaz T
    Cutan Ocul Toxicol; 2016 Mar; 35(1):1-7. PubMed ID: 25594252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow chemoprotection without compromise of chemotherapy efficacy in a rat brain tumor model.
    Neuwelt EA; Pagel MA; Kraemer DF; Peterson DR; Muldoon LL
    J Pharmacol Exp Ther; 2004 May; 309(2):594-9. PubMed ID: 14752063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of cellular electrical impedance sensing to assess in vitro cytotoxicity of anticancer drugs in a human kidney cell nephrotoxicity model.
    Xie F; Xu Y; Wang L; Mitchelson K; Xing W; Cheng J
    Analyst; 2012 Mar; 137(6):1343-50. PubMed ID: 22214987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of amine from platinum(II) complexes: implications for cisplatin inactivation, storage, and resistance.
    Lau JK; Deubel DV
    Chemistry; 2005 Apr; 11(9):2849-55. PubMed ID: 15744707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research.
    Ali BH; Al Moundhri MS
    Food Chem Toxicol; 2006 Aug; 44(8):1173-83. PubMed ID: 16530908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L- and D- methionine provide equivalent long term protection against CDDP-induced ototoxicity in vivo, with partial in vitro and in vivo retention of antineoplastic activity.
    Reser D; Rho M; Dewan D; Herbst L; Li G; Stupak H; Zur K; Romaine J; Frenz D; Goldbloom L; Kopke R; Arezzo J; Van De Water T
    Neurotoxicology; 1999 Oct; 20(5):731-48. PubMed ID: 10591510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The chemical reactivity of BNP7787 and its metabolite mesna with the cytostatic agent cisplatin: comparison with the nucleophiles thiosulfate, DDTC, glutathione and its disulfide GSSG.
    Verschraagen M; Kedde MA; Hausheer FH; Van Der Vijgh WJ
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):499-504. PubMed ID: 12715205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DFT Investigation of the Mechanism of Action of Organoiridium(III) Complexes As Anticancer Agents.
    Ritacco I; Russo N; Sicilia E
    Inorg Chem; 2015 Nov; 54(22):10801-10. PubMed ID: 26492153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The study of possibility to elevate antitumor activity and decrease of systemic toxic effects of cisplatin by its binding with deliganded albumin.
    Sakhno LA; Sarnatskaya VV; Yushko LA; Melnikov OR; Momot VY; Korneeva LN; Svintsiskiy VS; Korotich VG; Nechitaylo II; Nikolaev VG
    Exp Oncol; 2006 Dec; 28(4):303-7. PubMed ID: 17285115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity.
    Feghali JG; Liu W; Van De Water TR
    Laryngoscope; 2001 Jul; 111(7):1147-55. PubMed ID: 11568534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of platinum-induced toxicities and therapeutic index: mechanistic insights and first- and second-generation protecting agents.
    Hausheer FH; Kanter P; Cao S; Haridas K; Seetharamulu P; Reddy D; Petluru P; Zhao M; Murali D; Saxe JD; Yao S; Martinez N; Zukowski A; Rustum YM
    Semin Oncol; 1998 Oct; 25(5):584-99. PubMed ID: 9783598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beyond platinums: gold complexes as anticancer agents.
    Nardon C; Boscutti G; Fregona D
    Anticancer Res; 2014 Jan; 34(1):487-92. PubMed ID: 24403506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gold(III)-dithiocarbamato anticancer agents: activity, toxicology and histopathological studies in rodents.
    Marzano C; Ronconi L; Chiara F; Giron MC; Faustinelli I; Cristofori P; Trevisan A; Fregona D
    Int J Cancer; 2011 Jul; 129(2):487-96. PubMed ID: 20853318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance.
    Kelland LR; Sharp SY; O'Neill CF; Raynaud FI; Beale PJ; Judson IR
    J Inorg Biochem; 1999 Oct; 77(1-2):111-5. PubMed ID: 10626362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model.
    Berglin CE; Pierre PV; Bramer T; Edsman K; Ehrsson H; Eksborg S; Laurell G
    Cancer Chemother Pharmacol; 2011 Dec; 68(6):1547-56. PubMed ID: 21533919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selection of agents for prevention of cisplatin-induced hepatotoxicity.
    Liao Y; Lu X; Lu C; Li G; Jin Y; Tang H
    Pharmacol Res; 2008 Feb; 57(2):125-31. PubMed ID: 18282716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probing the interaction of bisintercalating (2,2':6',2″-terpyridine)platinum(II) complexes with glutathione and rabbit plasma.
    Harper BW; Morris TT; Gailer J; Aldrich-Wright JR
    J Inorg Biochem; 2016 Oct; 163():95-102. PubMed ID: 27453535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ameliorative effect of cysteine prodrug L-2-oxothiazolidine-4-carboxylic acid on cisplatin-induced nephrotoxicity in rats.
    Ali BH; Al Moundhri MS; Tag Eldin M; Nemmar A; Tanira MO
    Fundam Clin Pharmacol; 2007 Oct; 21(5):547-53. PubMed ID: 17868208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study of the oxidation behavior of sulfur-containing amino acids and glutathione by electrochemistry-mass spectrometry in the presence and absence of cisplatin.
    Zabel R; Weber G
    Anal Bioanal Chem; 2016 Feb; 408(4):1237-47. PubMed ID: 26670772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
    Brabec V; Nováková O
    Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.